Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 18 of 58, showing 10 Applications out of 576 total, starting on record 171, ending on 180

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

171.

ECCT/23/06/02   IMAGINE-TBM
    A Phase II, Randomized, Open-Label Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents with Tuberculous Meningitis: Improved Management with Antimicrobial AGents Isoniazid rifampiciN LinEzolid for TBM (IMAGINE-TBM).   
Principal Investigator(s)
1. Deborah Chepng\'eno Langat
Site(s) in Kenya
KEMRI/WRP CRC
 
24-10-2023 View

172.

ECCT/23/06/01   BREATHE
    Building Respiratory Support in East Africa Through High Flow versus Standard Flow Oxygen Evaluation   
Principal Investigator(s)
1. Elisabeth Riviello
Site(s) in Kenya
1. AIC Kijabe Hospital, Kiambu County (Kiambu county)
2. Nakuru Level 6 Hospital (Nakuru county)
 
04-10-2023 View

173.

ECCT/23/06/04   ARNASA
    A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE       
Principal Investigator(s)
1. Dr Jacqueline Mirera
Site(s) in Kenya
1. Clinical Research Health Network (CREA-N) (Machakos county)
2. KEMRI-CRDR Siaya Clinical Research Annex (Siaya county)
3. KEMRI-Mtwapa Clinical Annex (Kilifi county)
4. Center for Research In Tropical Medicine and Community Development (Nairobi City county)
5. Center for Research In Tropical Medicine and Community Development (Nairobi City county)
6. University of Nairobi Clinical Research Centre (Nairobi City county)
7. KEMRI-CRDR Clinical Research Annex (Nairobi City county)
 
24-08-2023 View

174.

ECCT/23/10/07   Fermented Food and Prediabetes
        A Study of the Hypoglycemic Effect of African Traditonal Fermented Foods amongst Prediabetic Adults.   
Principal Investigator(s)
1. Rosebella Iseme - Ondiek
Site(s) in Kenya
1. Aga Khan Outreach Centre Nairobi CBD/Town (Nairobi City county)
2. Aga Khan Outreach Centre Valley Arcade (Nairobi City county)
3. Aga Khan Outreach Centre Capital Centre (Nairobi City county)
4. Aga Khan Outreach Centre Kiambu Town (Kiambu county)
5. Aga Khan Outreach Centre Juja (Kiambu county)
6. Aga Khan Outreach Centre Ruiru (Kiambu county)
7. Aga Khan Outreach Centre Ongata Rongai (Kajiado county)
8. Aga Khan Outreach Centre Ngong (Kajiado county)
9. Aga Khan Outreach Centre Kitengela (Kajiado county)
 
17-01-2024 View

175.

ECCT/23/05/08   ACTIV-2d/A5407
    A Phase 3, multicenter, randomized, double-blind, 24-week study of the clinical and antiviral effect of S-217622 compared with placebo in non-hospitalized participants with COVID-19    
Principal Investigator(s)
1. Dr John Kinuthia
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. Victoria Biomedical Research Institute, (Kisumu county)
3. Kenyatta National Hospital (Nairobi City county)
4. KEMRI CCR – BUTERE SITE (Kakamega county)
5. Kenya Medical Research Institute/Walter Reed Project (Kericho county)
6. KEMRI – AHERO Clinical Trials Unit (Kisumu county)
 
27-08-2023 View

176.

ECCT/23/04/05   BiMVaC01
    A randomised, controlled clinical trial to assess and compare the immunogenicity, safety and reactogenicity of the bivalent Omicron BA.4/BA.5 adapted, and the original Wuhan-Hu-1-strain, BNT162b2 COVID-19 vaccine formulations in healthy unvaccinated East African adults.   
Principal Investigator(s)
1. NDUNGU FRANCIS
2. Said Jongo
Site(s) in Kenya
KEMRI-CGMRC Kilifi
 
06-07-2023 View

177.

ECCT/23/04/03   ACTIV-2d/A5407
    A Phase 3, multicenter, randomized, double-blind, 24-week study of the clinical and antiviral effect of S-217622 compared with placebo in non-hospitalized participants with COVID-19   
Principal Investigator(s)
1. Prof Abraham Mosigisi Siika
Site(s) in Kenya
1. MOI UNIVERSITY CLINICAL RESEARCH CENTRE (Uasin Gishu county)
2. Victoria Biomedical Research Institute, (Kisumu county)
3. Kenyatta National Hospital (Nairobi City county)
4. KEMRI CCR – BUTERE SITE (Kakamega county)
5. Kenya Medical Research Institute/Walter Reed Project (Kericho county)
6. KEMRI – AHERO Clinical Trials Units (Kisumu county)
 
14-06-2023 View

178.

ECCT/23/05/03   BrainCapture EEG Validation
          Usability and efficacy of an affordable, smartphone-connected EEG device to bridge the global gap in epilepsy diagnosis             
Principal Investigator(s)
1. Diraj Sokhi Sokhi
Site(s) in Kenya
Aga Khan University Hospital Nairobi
 
20-12-2023 View

179.

ECCT/23/04/02   Shigella 53G study in Kenya
    Safety and feasibility of a Shigella sonnei 53G controlled human infection model in Kenyan adults: a dose finding and dose verification study   
Principal Investigator(s)
1. Melissa Kapulu
2. Fredrick Sawe
Site(s) in Kenya
KEMRI-Wellcome Trust Research Programme (KWTRP) Centre for Geographic Medical Research - Coast (CGMRC), Kilifi, Kenya.
 
21-08-2024 View

180.

ECCT/23/05/02   A5384
    A Phase II, Randomized, Open-Label Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents with Tuberculous Meningitis: Improved Management with Antimicrobial AGents Isoniazid rifampiciN LinEzolid for TBM (IMAGINE-TBM)   
Principal Investigator(s)
1. Abraham Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. KEMRI Walter Reed Project (Kericho county)
 
12-10-2023 View